Primary objectives for pharmaceutical weight loss should focus on optimizing diet composition and nutrient intake in addition to managing side effects. Here, the study emphasized adhering to general guidance on higher protein intake calculated for g/kg for lean mass preservationpresenting meal replacement shakes as a relatively low-calorie, low-fat source of protein that can be supplemented with vitamins and minerals to help fill dietary gaps
Every year, PBA students follow their calling at companies like Google, Amazon, and more
Expectations and timeline Users typically report initial effects within the first two weeks of use
Continuing education is necessary to ensure evolving evidence reaches people living with type 2 diabetes
The SURPASS program, which evaluated tirzepatide in patients with type 2 diabetes across diverse treatment settings, consistently showed superior reductions in glycated hemoglobin compared with established therapies, including basal insulin and selective GLP 1 receptor agonists
Challenges of Cardio-Kidney Composite Outcomes in Large-Scale Clinical Trials
